19-7730817-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_198492.4(CLEC4G):ā€‹c.326T>Cā€‹(p.Leu109Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000392 in 1,532,392 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.0000066 ( 0 hom., cov: 31)
Exomes š‘“: 0.0000036 ( 0 hom. )

Consequence

CLEC4G
NM_198492.4 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.944
Variant links:
Genes affected
CLEC4G (HGNC:24591): (C-type lectin domain family 4 member G) This gene encodes a glycan-binding receptor and member of the C-type lectin family which plays a role in the immune response. C-type lectin receptors are pattern recognition receptors located on immune cells that play a role in the recognition and uptake of both self and non-self glycoproteins as well as mediating cell adhesion, glycoprotein clearance, and cell signaling functions. This gene's protein binds complex-type N-glycans of the viral envelope proteins of Ebola virus, West Nile filovirus, and SARS coronavirus, but not HIV or hepatitis C virus. In mouse, this protein has been shown to recognize activated T-cells and to negatively regulate T-cell receptor-mediated signalling. It also acts as a novel, liver-specific regulator of NK cell-mediated immunity in mouse. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11944902).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CLEC4GNM_198492.4 linkuse as main transcriptc.326T>C p.Leu109Pro missense_variant 5/9 ENST00000328853.11 NP_940894.1 Q6UXB4Q08G24Q6XYD1
CLEC4GNM_001244856.2 linkuse as main transcriptc.290T>C p.Leu97Pro missense_variant 5/9 NP_001231785.1 B7ZKQ2Q08G24Q6XYD1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CLEC4GENST00000328853.11 linkuse as main transcriptc.326T>C p.Leu109Pro missense_variant 5/91 NM_198492.4 ENSP00000327599.4 Q6UXB4
ENSG00000288669ENST00000678003.1 linkuse as main transcriptn.*871T>C non_coding_transcript_exon_variant 9/13 ENSP00000504497.1 A0A7I2YQT4
ENSG00000288669ENST00000678003.1 linkuse as main transcriptn.*871T>C 3_prime_UTR_variant 9/13 ENSP00000504497.1 A0A7I2YQT4

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
152042
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.00000362
AC:
5
AN:
1380350
Hom.:
0
Cov.:
39
AF XY:
0.00000294
AC XY:
2
AN XY:
681356
show subpopulations
Gnomad4 AFR exome
AF:
0.0000320
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000371
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
152042
Hom.:
0
Cov.:
31
AF XY:
0.00
AC XY:
0
AN XY:
74286
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000151

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 27, 2022The c.326T>C (p.L109P) alteration is located in exon 5 (coding exon 5) of the CLEC4G gene. This alteration results from a T to C substitution at nucleotide position 326, causing the leucine (L) at amino acid position 109 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.37
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
21
DANN
Benign
0.75
DEOGEN2
Benign
0.23
T
Eigen
Benign
-0.94
Eigen_PC
Benign
-0.95
FATHMM_MKL
Benign
0.050
N
LIST_S2
Benign
0.32
T
M_CAP
Benign
0.0034
T
MetaRNN
Benign
0.12
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
1.4
L
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-3.4
D
REVEL
Benign
0.025
Sift
Uncertain
0.0020
D
Sift4G
Benign
0.068
T
Polyphen
0.0030
B
Vest4
0.36
MutPred
0.45
Gain of glycosylation at L109 (P = 0.0363);
MVP
0.26
MPC
0.84
ClinPred
0.16
T
GERP RS
3.0
Varity_R
0.59
gMVP
0.71

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1232676170; hg19: chr19-7795703; API